Clinical Trials Logo

Filter by:
NCT ID: NCT02384161 Completed - Sarcopenia Clinical Trials

Exercise Intermittent Isometric Handgrip and Blood Flow Restriction

Start date: February 2015
Phase: N/A
Study type: Interventional

Isometric handgrip exercises are used to explain the effects of fatigue on the strength and activation of the muscles involved. Blood flow available at the time of exercise can influence this fatigue process, as some studies demonstrate changes in the pattern of muscle recruitment and strength recovery when the exercise is performed in combination with an external total obstruction (through a pressure cuff or tourniquet ) blood flow. Low intensity exercises associated with external partial obstruction of blood flow has been widely used and studied, mainly due to its effect on increasing strength and muscle hypertrophy, often comparable to those observed in conventional exercises (ie, without external obstruction of blood flow) High intensity. Despite the vast literature on this method, some topics need to be better informed about the underlying neuromuscular physiology to such effects (strength and hypertrophy) and the process of fatigue during isometric exercises associated with partial obstruction of blood flow. The aim of this study is to evaluate the acute effects on neuromuscular response in healthy adults undergoing an intermittent isometric exercise protocol with different levels of external compression. In a study of the "crossover" male volunteers will be submitted to three intermittent isometric exercise protocols (with a load of 45% of maximum voluntary isometric strength) associated with three different levels of obstruction (held by a pressure cuff) blood flow (total obstruction, partial obstruction and free blood flow). The protocols will be performed on three different days (with a minimum of 48 hours between them). Will be considered as acute neuromuscular responses spending time to failure in the task, the electromyographic activity of the flexor muscles of the wrist and fingers, and the recovery curve of maximum voluntary isometric strength after exercise. The main hypothesis of this study is that exercise is performed when associated with partial obstruction of blood flow, the time spent until the failed job is similar to that seen when exercise is performed with free blood flow, and the recovery of strength and electromyographic activity will be similar to that observed in the exercise associated with total obstruction of blood flow.

NCT ID: NCT02383784 Completed - Clinical trials for Type 2 Diabetes Mellitus

Effects of Low- or High-glycemic Index Diets on Metabolic and Inflammatory Responses in Diabetics

Start date: March 2007
Phase: N/A
Study type: Interventional

Background/Aims: Verify the effects of glycemic index (GI) on body composition, and on inflammatory and metabolic markers concentrations. Methods: Eighteen type 2 diabetics, (aged 42.4 + 5.1 years, BMI 29.2 + 4.8 kg.m-2) were randomly allocated to low GI (LGI) or high GI (HGI) groups. High or low GI meals were provided in the laboratory twice a day during 30 consecutive days. The other meals were consumed under free living condition and subjects were instructed to select foods presenting GI values corresponding to the allocated group. Body composition (body mass index, body fat percentage, waist circumference and waist-hip ratio), and inflammatory markers concentrations (interleukin-6, tumor necrosis factor-alpha, high molecular weight adiponectin, ultra-sensitive C-reactive protein and fibrinogen) and metabolic markers (glucose, insulin, total cholesterol, HDL cholesterol, free fatty acids, triglycerides and fructosamine) were assessed at baseline and after intervention. Food intake was monitored during the study. The criterion for statistical significance was P<0.05.

NCT ID: NCT02383589 Completed - Pemphigus Vulgaris Clinical Trials

A Study to Evaluate the Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil (MMF) in Participants With Pemphigus Vulgaris (PV)

Start date: May 26, 2015
Phase: Phase 3
Study type: Interventional

This is a Phase III, randomized, double-blind, double-dummy, active-comparator, parallel-arm, multicenter study to evaluate the efficacy and safety of rituximab compared with MMF in participants with moderate-to-severely active PV requiring 60-120 milligrams per day (mg/day) oral prednisone or equivalent. Participants must have a confirmed diagnosis of PV within the previous 24 months (by skin or mucosal biopsy and immunohistochemistry) and evidence of active disease at screening. Approximately 135 participants will be enrolled at up to 60 centers worldwide. Participants will be randomized in a 1:1 ratio to receive either rituximab plus MMF placebo or rituximab placebo plus MMF. Randomization will be stratified by duration of illness. The study will consist of three periods: a screening period of up to 28 days, a 52-week double-blind treatment period, and a 48-week safety follow up period that begins at the time of study treatment completion or discontinuation.

NCT ID: NCT02383576 Completed - Breast Cancer Clinical Trials

Retrospective Data Collection: Post Study Treatment Anticancer Therapy From IMELDA MO22223

Start date: April 30, 2015
Phase:
Study type: Observational

This study aims to understand better the effective results from the IMELDA MO22223 P-trial (NCT00929240) and see if the anti-cancer therapies given during its follow-up time after study treatments were terminated possibly had an effect on efficacy results.

NCT ID: NCT02383069 Completed - Children Clinical Trials

Pulmonary Rehabilitation in Asthmatic Patient

Start date: February 2015
Phase: N/A
Study type: Interventional

Asthma is one of the main chronic diseases in childhood and it is characterized by the inflammation of airways. Individuals with chronic lung disease are more susceptible to present reduction in exercise tolerance due to pulmonary limitations. The pulmonary rehabilitation may improve the physical capacity in asthmatic patients, as observed in other chronic lung diseases.

NCT ID: NCT02382016 Completed - Clinical trials for Portopulmonary Hypertension

PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial

PORTICO
Start date: June 23, 2015
Phase: Phase 4
Study type: Interventional

24-week study to evaluate the efficacy and safety of macitentan for the treatment of portopulmonary hypertension.

NCT ID: NCT02380755 Completed - Obesity Clinical Trials

Clomiphene Citrate for the Treatment of Obesity Related Male Hypogonadism

Start date: April 2015
Phase: Phase 2
Study type: Interventional

Hypogonadism is a clinical condition that can be associated with obesity in man. Controversy exists regarding if its a condition that needs to be treated. The standard Testosterone Therapy is associated with increase in cardiovascular risks, according to some studies, and leads to infertility. The use of Clomiphene Citrate in this sub population of obese man as an alternative treatment option is not well studied. The aim of this protocol is to evaluate the cardiovascular risks, metabolic and hormonal parameters in a double blinded randomized placebo trial.

NCT ID: NCT02380261 Completed - Skin Tolerance Clinical Trials

A Clinical Study of Systane® Lid Wipes in Brazil

Start date: September 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to verify the skin and ocular tolerance of the product Systane® Lid Wipes.

NCT ID: NCT02378337 Completed - Hodgkin Disease Clinical Trials

Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image Quality

pet-ct
Start date: September 2014
Phase: N/A
Study type: Observational

Identify the best combination of predictive variables that influence ionizing radiation dose and improved image quality through analysis and quantification of PET-CT images in simulators and patients.

NCT ID: NCT02377388 Completed - Clinical trials for Platelet Aggregation During Acute Myocardial Infarction

DPP-4 Inhibitors and Acute Myocardial Infarction:Effects on Platelet Function

Start date: February 7, 2017
Phase: Phase 3
Study type: Interventional

Cardiovascular events are the main cause of mortality in diabetic patients ,on the other hand,during an acute myocardial infarction(AMI),hyperglycemia increases mortality and is related to different pathophysiologic processes. More important evidence regarding the effect of glycemic control on AMI patients prognosis is contradictory,and the potential benefits of dipeptidyl peptidase-4 inhibitors(DPP4-i) in this setting is unknown. The aim of this study is to assess the presence of pleiotropic effects of DPP4-i(sitagliptin or saxagliptin) and their relationship with glycemic control during in-hospital phase of AMI.